FindTrial
Sign In

Comparison of two sedative drugs fentanyl and dexmedetomidine as an add on drug to bupivacaine for regional anaesthesia of upper limb surgeries

Comparison of fentanyl and dexmedetomidine as an adjuvant to bupivacaine in ultarsound guided supraclavicular brachial plexus block in upper limb surgeries: a randomized-double blind prospective study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/04/013254
Enrollment
64
Registered
2018-04-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- ASA I/II/III

Interventions

Intervention1: comparison of two drugs as an adjuvant to bupivacaine in ultrasound guided supraclavicular brachial plexus block in upper limb surgeries: Patients will be randomly assigned into two gro

Sponsors

Bhagat Phool Singh Government Medical College For Women
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. American Society of Anesthesiologistâ??s Grades I to III 2. Patients of either sex 3. Aged 18-65 years

Exclusion criteria

Exclusion criteria: 1.Patients with known hypersensitivity to local anesthetic drugs 2.Bleeding disorders 3.Pre-existing neuropathy 4.Any hepatic, renal, neurological, psychiatric, or neuromuscular diseases 5.Minor/ pregnancy/ lactation/more than 65 years age will be excluded from the study

Design outcomes

Primary

MeasureTime frame
1.Analgesic Efficacy in terms of Onset And Duration Of Motor And Sensory BlockadeTimepoint: From The Time Of Drug Delivery To 24 Hours Of Postoperatively—

Secondary

MeasureTime frame
Intraoperative Vitals and Heart Rate , Blood Pressure , Sedation Till 24 Hours PostoperativelyTimepoint: From The Time Of Drug Delivery To 24 Hours Of Postoperatively—

Countries

India

Contacts

Public ContactSandeep Mann

Bhagat Phool Singh Government Medical College For Women

pranavbansal1@gmail.com8222007555

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026